Literature DB >> 26567920

IL-15 functions as a danger signal to regulate tissue-resident T cells and tissue destruction.

Bana Jabri1, Valérie Abadie2.   

Abstract

In this Opinion article, we discuss the function of tissues as a crucial checkpoint for the regulation of effector T cell responses, and the notion that interleukin-15 (IL-15) functions as a danger molecule that communicates to the immune system that the tissue is under attack and poises it to mediate tissue destruction. More specifically, we propose that expression of IL-15 in tissues promotes T helper 1 cell-mediated immunity and provides co-stimulatory signals to effector cytotoxic T cells to exert their effector functions and drive tissue destruction. Therefore, we think that IL-15 contributes to tissue protection by promoting the elimination of infected cells but that when its expression is chronically dysregulated, it can promote the development of complex T cell-mediated disorders associated with tissue destruction, such as coeliac disease and type 1 diabetes.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26567920      PMCID: PMC5079184          DOI: 10.1038/nri3919

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN: 1474-1733            Impact factor:   53.106


  159 in total

Review 1.  Tissue-mediated control of immunopathology in coeliac disease.

Authors:  Bana Jabri; Ludvig M Sollid
Journal:  Nat Rev Immunol       Date:  2009-12       Impact factor: 53.106

2.  The role of IL-15 in activating STAT5 and fine-tuning IL-17A production in CD4 T lymphocytes.

Authors:  Pushpa Pandiyan; Xiang-Ping Yang; Senthil S Saravanamuthu; Lixin Zheng; Satoru Ishihara; John J O'Shea; Michael J Lenardo
Journal:  J Immunol       Date:  2012-09-19       Impact factor: 5.422

Review 3.  Interleukin-15 biology and its therapeutic implications in cancer.

Authors:  Jason C Steel; Thomas A Waldmann; John C Morris
Journal:  Trends Pharmacol Sci       Date:  2011-10-25       Impact factor: 14.819

Review 4.  Autoimmune thyroid disorders.

Authors:  Alessandro Antonelli; Silvia Martina Ferrari; Alda Corrado; Andrea Di Domenicantonio; Poupak Fallahi
Journal:  Autoimmun Rev       Date:  2014-10-25       Impact factor: 9.754

Review 5.  Immune infiltration in human cancer: prognostic significance and disease control.

Authors:  Wolf H Fridman; Jérome Galon; Marie-Caroline Dieu-Nosjean; Isabelle Cremer; Sylvain Fisson; Diane Damotte; Franck Pagès; Eric Tartour; Catherine Sautès-Fridman
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

6.  Cutting edge: the role of IFN-α receptor and MyD88 signaling in induction of IL-15 expression in vivo.

Authors:  Sara L Colpitts; Thomas A Stoklasek; Courtney R Plumlee; Joshua J Obar; Caiying Guo; Leo Lefrançois
Journal:  J Immunol       Date:  2012-02-10       Impact factor: 5.422

7.  Intraepithelial type 1 innate lymphoid cells are a unique subset of IL-12- and IL-15-responsive IFN-γ-producing cells.

Authors:  Anja Fuchs; William Vermi; Jacob S Lee; Silvia Lonardi; Susan Gilfillan; Rodney D Newberry; Marina Cella; Marco Colonna
Journal:  Immunity       Date:  2013-02-28       Impact factor: 31.745

8.  CD8+ T cell-derived IFN-γ prevents infection by a second heterologous virus.

Authors:  Laura Valentine; Rashaun Potts; Mary Premenko-Lanier
Journal:  J Immunol       Date:  2012-11-07       Impact factor: 5.422

9.  Selective expansion of intraepithelial lymphocytes expressing the HLA-E-specific natural killer receptor CD94 in celiac disease.

Authors:  B Jabri; N P de Serre; C Cellier; K Evans; C Gache; C Carvalho; J F Mougenot; M Allez; R Jian; P Desreumaux; J F Colombel; C Matuchansky; H Cugnenc; M Lopez-Botet; E Vivier; A Moretta; A I Roberts; E C Ebert; D Guy-Grand; N Brousse; J Schmitz; N Cerf-Bensussan
Journal:  Gastroenterology       Date:  2000-05       Impact factor: 22.682

10.  Interleukin 15 mediates epithelial changes in celiac disease.

Authors:  L Maiuri; C Ciacci; S Auricchio; V Brown; S Quaratino; M Londei
Journal:  Gastroenterology       Date:  2000-10       Impact factor: 22.682

View more
  107 in total

1.  Bench-to-bedside translation of interleukin-15 for immunotherapy: principles and challenges.

Authors:  Chalet Tan; Thomas A Waldmann
Journal:  Expert Opin Drug Deliv       Date:  2020-05-19       Impact factor: 6.648

Review 2.  Tissue-Resident Cytolytic Innate Lymphocytes in Cancer.

Authors:  Briana G Nixon; Ming O Li
Journal:  J Immunol       Date:  2018-01-15       Impact factor: 5.422

3.  Epithelial IL-15 Is a Critical Regulator of γδ Intraepithelial Lymphocyte Motility within the Intestinal Mucosa.

Authors:  Madeleine D Hu; Alexander D Ethridge; Rebecca Lipstein; Sushil Kumar; Yitang Wang; Bana Jabri; Jerrold R Turner; Karen L Edelblum
Journal:  J Immunol       Date:  2018-06-08       Impact factor: 5.422

4.  Dendritic Cell-Derived IL-32α: A Novel Inhibitory Cytokine of NK Cell Function.

Authors:  Laurent Gorvel; Daniel Korenfeld; Thomas Tung; Eynav Klechevsky
Journal:  J Immunol       Date:  2017-07-12       Impact factor: 5.422

5.  CD4 effector T cell differentiation is controlled by IL-15 that is expressed and presented in trans.

Authors:  Adam T Waickman; Davinna L Ligons; SuJin Hwang; Joo-Young Park; Vanja Lazarevic; Noriko Sato; Changwan Hong; Jung-Hyun Park
Journal:  Cytokine       Date:  2017-08-12       Impact factor: 3.861

6.  Distinct human circulating NKp30+FcεRIγ+CD8+ T cell population exhibiting high natural killer-like antitumor potential.

Authors:  Margareta P Correia; Ana Stojanovic; Katharina Bauer; Dilafruz Juraeva; Lars-Oliver Tykocinski; Hanns-Martin Lorenz; Benedikt Brors; Adelheid Cerwenka
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-12       Impact factor: 11.205

7.  Chronic Inflammation Permanently Reshapes Tissue-Resident Immunity in Celiac Disease.

Authors:  Toufic Mayassi; Kristin Ladell; Herman Gudjonson; James E McLaren; Dustin G Shaw; Mai T Tran; Jagoda J Rokicka; Ian Lawrence; Jean-Christophe Grenier; Vincent van Unen; Cezary Ciszewski; Matthew Dimaano; Hoda E Sayegh; Vinod Kumar; Cisca Wijmenga; Peter H R Green; Ranjana Gokhale; Hilary Jericho; Carol E Semrad; Stefano Guandalini; Aaron R Dinner; Sonia S Kupfer; Hugh H Reid; Luis B Barreiro; Jamie Rossjohn; David A Price; Bana Jabri
Journal:  Cell       Date:  2019-02-07       Impact factor: 41.582

8.  IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection.

Authors:  Souheil-Antoine Younes; Michael L Freeman; Joseph C Mudd; Carey L Shive; Arnold Reynaldi; Soumya Panigrahi; Jacob D Estes; Claire Deleage; Carissa Lucero; Jodi Anderson; Timothy W Schacker; Miles P Davenport; Joseph M McCune; Peter W Hunt; Sulggi A Lee; Sergio Serrano-Villar; Robert L Debernardo; Jeffrey M Jacobson; David H Canaday; Rafick-Pierre Sekaly; Benigno Rodriguez; Scott F Sieg; Michael M Lederman
Journal:  J Clin Invest       Date:  2016-06-20       Impact factor: 14.808

Review 9.  Alopecia areata: Animal models illuminate autoimmune pathogenesis and novel immunotherapeutic strategies.

Authors:  Amos Gilhar; Adam G Schrum; Amos Etzioni; Herman Waldmann; Ralf Paus
Journal:  Autoimmun Rev       Date:  2016-03-10       Impact factor: 9.754

10.  Recombinant Human Interleukin-15 and Anti-PD-L1 Combination Therapy Expands a CXCR3+PD1-/low CD8 T-Cell Subset in Simian Immunodeficiency Virus-Infected Rhesus Macaques.

Authors:  Ping Chen; Hui Chen; Maha Moussa; Jie Cheng; Tong Li; Jing Qin; Jeffrey D Lifson; Michael C Sneller; Ludmila Krymskaya; Steven Godin; H Clifford Lane; Marta Catalfamo
Journal:  J Infect Dis       Date:  2020-02-03       Impact factor: 5.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.